IE42952B1 - Tablet formulation - Google Patents
Tablet formulationInfo
- Publication number
- IE42952B1 IE42952B1 IE272/76A IE27276A IE42952B1 IE 42952 B1 IE42952 B1 IE 42952B1 IE 272/76 A IE272/76 A IE 272/76A IE 27276 A IE27276 A IE 27276A IE 42952 B1 IE42952 B1 IE 42952B1
- Authority
- IE
- Ireland
- Prior art keywords
- sulphonamide
- tablet
- tablet according
- particle size
- disintegrating agent
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB6174/75A GB1533243A (en) | 1975-02-13 | 1975-02-13 | Tablet formulation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IE42952L IE42952L (en) | 1976-08-13 |
| IE42952B1 true IE42952B1 (en) | 1980-11-19 |
Family
ID=9809772
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IE272/76A IE42952B1 (en) | 1975-02-13 | 1976-02-12 | Tablet formulation |
Country Status (14)
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1601833A (en) * | 1978-02-06 | 1981-11-04 | Wellcome Found | Antacid formulation |
| ZA822995B (en) * | 1981-05-21 | 1983-12-28 | Wyeth John & Brother Ltd | Slow release pharmaceutical composition |
| WO1992013527A1 (en) * | 1991-01-30 | 1992-08-20 | The Wellcome Foundation Limited | Water-dispersible tablets |
| US5629016A (en) * | 1991-01-30 | 1997-05-13 | Glaxo Wellcome Inc. | Water-dispersible tablets |
| US5698226A (en) * | 1993-07-13 | 1997-12-16 | Glaxo Wellcome Inc. | Water-dispersible tablets |
| US20040109889A1 (en) | 2002-12-04 | 2004-06-10 | Bunick Frank J. | Surface treatment composition for soft substrates |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1460302A (en) * | 1973-05-23 | 1977-01-06 | Wellcome Found | Tablet formulation |
| GB1499672A (en) * | 1974-02-14 | 1978-02-01 | Wellcome Found | Tablet formulation |
-
1975
- 1975-02-13 GB GB6174/75A patent/GB1533243A/en not_active Expired
-
1976
- 1976-02-12 BE BE164281A patent/BE838507A/xx unknown
- 1976-02-12 CA CA245,882A patent/CA1052267A/en not_active Expired
- 1976-02-12 FI FI760340A patent/FI760340A7/fi not_active Application Discontinuation
- 1976-02-12 DK DK57376*#A patent/DK57376A/da unknown
- 1976-02-12 HU HU76WE00000534A patent/HU171201B/hu unknown
- 1976-02-12 DE DE19762605656 patent/DE2605656A1/de not_active Withdrawn
- 1976-02-12 ZA ZA760829A patent/ZA76829B/xx unknown
- 1976-02-12 JP JP51014332A patent/JPS51106711A/ja active Pending
- 1976-02-12 IE IE272/76A patent/IE42952B1/en unknown
- 1976-02-12 SE SE7601564A patent/SE7601564L/xx unknown
- 1976-02-12 IL IL7649024A patent/IL49024A/xx unknown
- 1976-02-12 FR FR7603829A patent/FR2300550A1/fr active Granted
- 1976-02-12 NL NL7601423A patent/NL7601423A/xx not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| BE838507A (fr) | 1976-08-12 |
| ZA76829B (en) | 1977-09-28 |
| FR2300550B1 (enrdf_load_stackoverflow) | 1979-09-21 |
| IE42952L (en) | 1976-08-13 |
| DK57376A (da) | 1976-08-14 |
| AU1110876A (en) | 1977-08-18 |
| IL49024A0 (en) | 1976-04-30 |
| GB1533243A (en) | 1978-11-22 |
| IL49024A (en) | 1979-03-12 |
| FR2300550A1 (fr) | 1976-09-10 |
| FI760340A7 (enrdf_load_stackoverflow) | 1976-08-14 |
| NL7601423A (nl) | 1976-08-17 |
| SE7601564L (sv) | 1976-08-16 |
| DE2605656A1 (de) | 1976-08-26 |
| HU171201B (hu) | 1977-11-28 |
| CA1052267A (en) | 1979-04-10 |
| JPS51106711A (enrdf_load_stackoverflow) | 1976-09-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4209513A (en) | Tablet formulation | |
| US4562024A (en) | Process for preparing granulate containing poorly compressible medicinally active matter | |
| AU611999B2 (en) | Pharmaceutical granulate | |
| US4950484A (en) | Pharmaceutical tablet, pharmaceutical granulate and process for their preparation | |
| KR100294154B1 (ko) | 부프로피온함유서방형정제 | |
| EP1847260B1 (en) | Solid dispersion preparation | |
| CA1117418A (en) | Antacid tablet formulation | |
| US5087454A (en) | Ibuprofen tablet | |
| AU702585B2 (en) | Pharmaceutical formulations of cefaclor | |
| US5470580A (en) | Directly-compressible naproxen or naproxen sodium compositions | |
| IE42952B1 (en) | Tablet formulation | |
| IL46629A (en) | Tablets comprising a 2,4-diaminopyrimidine and a sulphonamide | |
| EP0064388B1 (en) | Retard oral pharmaceutical compositions | |
| GB2124078A (en) | Processes for preparing tablets by a modified wet-granulation technique | |
| Ford et al. | Preparation, properties and ageing of tablets prepared from the chlorpropamide-urea solid dispersion | |
| Odunayo et al. | Evaluation of the binding property of some binders in metronidazole tablet formulation | |
| IE42958B1 (en) | Tablet formulation | |
| JPS6328414B2 (enrdf_load_stackoverflow) | ||
| Chowhan et al. | Effect of intergranular versus intragranular cornstarch on tablet friability and in vitro dissolution | |
| Majekodunmi et al. | Development of Novel Drug Delivery System Using Calcium Silicate | |
| Rubinstein et al. | The effect of four tablet binders on the bioavailability of frusemide from 40MG tablets | |
| JP2521848B2 (ja) | 成形され、圧縮された徐放性単位投薬形態の調製法およびこうして得られた圧縮単位投薬形態 | |
| Banakar et al. | Evaluation of a low and a high density polyethylene as potential prolonged release tablet excipients | |
| Mohammed et al. | Evaluating the Flow and Release Profiles of Ibuprofen Formulations by Increasing the Binder Concentration | |
| Shanta | Determination of variation in flow property of different formulas of polyethylene Glycol along with Amlodipine and Propranolol |